Enzymes Market Share to reach $10.2 billion by 2031 | Growth With Recent Trends & Demand

Satellite Payload Market

According to the report published by Allied Market Research, the global enzymes market size is estimated to reach $10.2 billion by 2031, having endorsed a value of $5.8 billion in 2021, and exhibiting a CAGR of 6.0% from 2022 to 2031. This market report provides an in-depth examination of top market segments, leading investment pockets, market dynamics, market capacity and forecasts, competitive analysis, and regional analysis. It is an essential resource for the stakeholders, and leading market players to strategic plan and enhance their competitive advantage.

High prevalence of chronic diseases, increase in prevalence of digestive disorders, surge in demand of biofuels drive the enzymes market during the forecast period.

Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/708

The factors that drive the growth of the global enzymes market share include upsurge in demand for cellulosic- & amylase-based biofuels, rise in need for effective pharmaceuticals & cosmetics, upsurge in usage of functional food & beverages (that contain enzymes), and increase in usage of enzyme-based techniques for detection & treatment of various chronic diseases. However, restrictions related to chemical properties of enzymes and safety issues arising due to the contamination of enzymes impede the market growth.

Enzymes Market Drivers:

  • The usage of enzymes in food and beverage companies to transform complex molecules into simpler molecules
  • The rise in the prevalence of chronic diseases, including digestive disorders and inflammations, as well as cancer and AIDS
  • Surge in demand for enzymes in the pharmaceutical industry to facilitate the synthesis of intermediates in the production of active pharmaceutical ingredients (APIs) to produce effective medicinal drugs
  • The increase in the demand for renewable sources of energy, including biofuels.

Recent strategies in Enzymes Market

  • In April 2022, seqWell Inc. and Codexis, Inc. had announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. This collaboration and investment has enabled seqWell to continue rapidly advancing its commercialization of new and existing products in the fast-growing genomics and next generation sequencing (NGS) library prep market.
  • In June 2020, Novozymes launched eco-friendly “umami flavoring” made with enzymes for enhancing the taste associated with cooked meat.
  • In June 2020, DSM launched “DelvoPlant” range of enzymes for improvising taste, sweetness and texture of plant-based drinks. This new product will aid in increased capacity or reduced costs which is particularly important given the current volatility in the energy industry.

Enzymes Market Segmentation Overview

By source, the microorganisms segment accounted for the largest market share in 2021, holding to more than half of the global enzymes market revenue, and is projected to lead the trail during the forecast timeframe. On the other hand, the plants segment would display the fastest CAGR of 7.0% from 2022 to 2031. The animals segment is also studied in the report.

By application, the household care segment accounted for the major market share in 2021, acquiring nearly one-third of the global enzymes market revenue. Furthermore, the pharmaceutical and biotechnology segment would showcase the fastest CAGR of 7.3% from 2022 to 2031. The report also examined the food and beverages, feed and others, and bioenergy segment in the report.

By type, the carbohydrase segment held the major market share in 2021, contributing to more than two-fifths of the global enzymes market revenue, and is expected to rule the roost by 2031. However, the polymerase and nuclease segment would portray the fastest CAGR of 9.6% from 2022 to 2031. The report also discusses the protease, lipase, and other segments in this report.

For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/708

By region, North America garnered the largest market share in 2021 and accounted for more than one-third of the global enzymes market revenue. Simultaneously, the Asia-Pacific region would cite the fastest CAGR of 7.9% from 2022 to 2031. The other provinces discussed in the report include Europe and LAMEA.

The prominent players that have been analyzed and identified in the global enzymes market include, THERMO FISHER SCIENTIFIC INC. (AFFYMETRIX, INC.), AB ENZYMES GmbH, Koninklijke DSM N.V., Advanced Enzyme Technologies Ltd., Codexis, Inc., DUPONT DE NEMOURS, INC., HOFFMANN-LA ROCHE LTD., BASF SE, NOVOZYMES A/S, and F. AMANO ENZYME INC. These leading players have adopted a variety of strategies such as partnership, geographic expansion, joint ventures, new product launches, and others to demonstrate their presence in the market.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the consumer healthcare market analysis from 2022 to 2032 to identify the prevailing Consumer Healthcare Market Opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the consumer healthcare market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global consumer healthcare market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the consumer healthcare market players.
  • The report includes the analysis of the regional as well as global consumer healthcare market trends, key players, market segments, application areas, and market growth strategies.

Read More:

ENT Disorder Treatment Market Exhibits Remarkable Growth Opportunity (2025-2031)

Hemodialysis Market to Reach US$ 111.8 Billion in 2032, Says Allied Market Research

Contact Details:

David Correa

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

[email protected]

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

 

Allied Market Research

Allied Market Research

Allied Market Research (AMR) is approved by the Newstrail editorial board to share timely, data-driven insights. As a trusted leader in market research and analysis across multiple industries, AMR delivers in-depth reports and expert commentary to help businesses stay ahead of emerging trends.